c-Fos and related immediate early gene products as markers of activity in neuroendocrine systems

Gloria E. Hoffman, M (Susan) Smith, Joseph G. Verbalis

Research output: Contribution to journalArticle

491 Citations (Scopus)

Abstract

Expression of c-Fos, or other immediate early gene products, by individual neurons can be used as a marker of cell activation, making staining of these proteins an extremely useful technique for functional anatomical mapping of neuroendocrine systems. Because these proteins are located in the nucleus, identification of the phenotype of the activated neuron using substances located within the cytoplasm can be accomplished with standard double-labeling immunocytochemical techniques. Although it is clear that neurons have the capacity to express a number of immediate early gene products, what remains to be established is whether there is a different pattern of expression following various stimuli. In our studies, we focus primarily on expression of one immediate early gene product, the c-Fos protein. We also include some experiments using expression of other members of the Fos family and Jun proteins as markers for neuronal activation. Our studies describe uses of c-Fos expression in both parvocellular and magnocellular hypothalamic systems to address the following issues: (a) identification of neuroendocrine cells activated by specific treatments and conditions, (b) ascertainment of functional differences in subpopulations activated by specific stimuli, (c) evaluation of neuronal activity in complex areas containing multiple neuroendocrine systems, (d) identification of other brain areas activated in conjunction with neuroendocrine systems following specific stimuli, (e) analysis of connectivity of activated neuroendocrine systems with other parts of the brain, and (f) identification of stimuli that decrease neuronal activity. The neuroendocrine systems studied include those that secrete arginine vasopressin (AVP), oxytocin (OT), corticotropin-releasing hormone (CRH), luteinizing hormone-releasing hormone (LHRH), and dopamine (DA). The use of c-Fos expression has permitted functional neuroanatomical mapping of these systems in response to specific stimuli such as cholecystokinin (CCK), hyperosmolality, and volume depletion, or during various physiological states such as the proestrous ovulatory luteinizing hormone (LH) surge and lactation. Although the use of c-Fos as a marker of neuronal activation will continue to be an extremely powerful technique, future studies will also be directed at relating immediate early gene expression to changes in neuroendocrine gene expression. To this end, we have shown that both c-Fos and c-Jun are expressed in neuroendocrine neurons in response to a number of stimuli, setting the stage for potential regulatory drive to genes containing AP-1 binding sites. In addition, by using double-label in situ hybridization techniques, it should be possible to compare gene expression in activated neurons (as determined by the presence of c-Fos mRNA) and unactivated neurons, thus permitting immediate early gene expression to move beyond its present use as a marker of neuronal activation to an assessment of its role in the promotion of specific neuropeptide gene expression.

Original languageEnglish (US)
Pages (from-to)173-213
Number of pages41
JournalFrontiers in Neuroendocrinology
Volume14
Issue number3
StatePublished - 1993
Externally publishedYes

Fingerprint

Neurosecretory Systems
Immediate-Early Genes
Neurons
Gene Expression
Proto-Oncogene Proteins c-fos
Vasotocin
Neuroendocrine Cells
Proteins
Arginine Vasopressin
Corticotropin-Releasing Hormone
Cholecystokinin
Transcription Factor AP-1
Brain
Luteinizing Hormone
Neuropeptides
Lactation
Gonadotropin-Releasing Hormone
In Situ Hybridization
Dopamine
Cytoplasm

Keywords

  • Arginine vasopressin
  • c-Fos
  • Cholecystokinin
  • Corticotropin releasing hormone
  • Dopamine
  • Fos-related antigens
  • Immediate early gene expression
  • Jun
  • Luteinizing hormone releasing hormone
  • Neuroanatomical mapping
  • Oxytocin
  • Protooncogenes

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrine and Autonomic Systems

Cite this

c-Fos and related immediate early gene products as markers of activity in neuroendocrine systems. / Hoffman, Gloria E.; Smith, M (Susan); Verbalis, Joseph G.

In: Frontiers in Neuroendocrinology, Vol. 14, No. 3, 1993, p. 173-213.

Research output: Contribution to journalArticle

Hoffman, Gloria E. ; Smith, M (Susan) ; Verbalis, Joseph G. / c-Fos and related immediate early gene products as markers of activity in neuroendocrine systems. In: Frontiers in Neuroendocrinology. 1993 ; Vol. 14, No. 3. pp. 173-213.
@article{43eef17861c94fe9823936c9e9d9b88e,
title = "c-Fos and related immediate early gene products as markers of activity in neuroendocrine systems",
abstract = "Expression of c-Fos, or other immediate early gene products, by individual neurons can be used as a marker of cell activation, making staining of these proteins an extremely useful technique for functional anatomical mapping of neuroendocrine systems. Because these proteins are located in the nucleus, identification of the phenotype of the activated neuron using substances located within the cytoplasm can be accomplished with standard double-labeling immunocytochemical techniques. Although it is clear that neurons have the capacity to express a number of immediate early gene products, what remains to be established is whether there is a different pattern of expression following various stimuli. In our studies, we focus primarily on expression of one immediate early gene product, the c-Fos protein. We also include some experiments using expression of other members of the Fos family and Jun proteins as markers for neuronal activation. Our studies describe uses of c-Fos expression in both parvocellular and magnocellular hypothalamic systems to address the following issues: (a) identification of neuroendocrine cells activated by specific treatments and conditions, (b) ascertainment of functional differences in subpopulations activated by specific stimuli, (c) evaluation of neuronal activity in complex areas containing multiple neuroendocrine systems, (d) identification of other brain areas activated in conjunction with neuroendocrine systems following specific stimuli, (e) analysis of connectivity of activated neuroendocrine systems with other parts of the brain, and (f) identification of stimuli that decrease neuronal activity. The neuroendocrine systems studied include those that secrete arginine vasopressin (AVP), oxytocin (OT), corticotropin-releasing hormone (CRH), luteinizing hormone-releasing hormone (LHRH), and dopamine (DA). The use of c-Fos expression has permitted functional neuroanatomical mapping of these systems in response to specific stimuli such as cholecystokinin (CCK), hyperosmolality, and volume depletion, or during various physiological states such as the proestrous ovulatory luteinizing hormone (LH) surge and lactation. Although the use of c-Fos as a marker of neuronal activation will continue to be an extremely powerful technique, future studies will also be directed at relating immediate early gene expression to changes in neuroendocrine gene expression. To this end, we have shown that both c-Fos and c-Jun are expressed in neuroendocrine neurons in response to a number of stimuli, setting the stage for potential regulatory drive to genes containing AP-1 binding sites. In addition, by using double-label in situ hybridization techniques, it should be possible to compare gene expression in activated neurons (as determined by the presence of c-Fos mRNA) and unactivated neurons, thus permitting immediate early gene expression to move beyond its present use as a marker of neuronal activation to an assessment of its role in the promotion of specific neuropeptide gene expression.",
keywords = "Arginine vasopressin, c-Fos, Cholecystokinin, Corticotropin releasing hormone, Dopamine, Fos-related antigens, Immediate early gene expression, Jun, Luteinizing hormone releasing hormone, Neuroanatomical mapping, Oxytocin, Protooncogenes",
author = "Hoffman, {Gloria E.} and Smith, {M (Susan)} and Verbalis, {Joseph G.}",
year = "1993",
language = "English (US)",
volume = "14",
pages = "173--213",
journal = "Frontiers in Neuroendocrinology",
issn = "0091-3022",
publisher = "Academic Press Inc.",
number = "3",

}

TY - JOUR

T1 - c-Fos and related immediate early gene products as markers of activity in neuroendocrine systems

AU - Hoffman, Gloria E.

AU - Smith, M (Susan)

AU - Verbalis, Joseph G.

PY - 1993

Y1 - 1993

N2 - Expression of c-Fos, or other immediate early gene products, by individual neurons can be used as a marker of cell activation, making staining of these proteins an extremely useful technique for functional anatomical mapping of neuroendocrine systems. Because these proteins are located in the nucleus, identification of the phenotype of the activated neuron using substances located within the cytoplasm can be accomplished with standard double-labeling immunocytochemical techniques. Although it is clear that neurons have the capacity to express a number of immediate early gene products, what remains to be established is whether there is a different pattern of expression following various stimuli. In our studies, we focus primarily on expression of one immediate early gene product, the c-Fos protein. We also include some experiments using expression of other members of the Fos family and Jun proteins as markers for neuronal activation. Our studies describe uses of c-Fos expression in both parvocellular and magnocellular hypothalamic systems to address the following issues: (a) identification of neuroendocrine cells activated by specific treatments and conditions, (b) ascertainment of functional differences in subpopulations activated by specific stimuli, (c) evaluation of neuronal activity in complex areas containing multiple neuroendocrine systems, (d) identification of other brain areas activated in conjunction with neuroendocrine systems following specific stimuli, (e) analysis of connectivity of activated neuroendocrine systems with other parts of the brain, and (f) identification of stimuli that decrease neuronal activity. The neuroendocrine systems studied include those that secrete arginine vasopressin (AVP), oxytocin (OT), corticotropin-releasing hormone (CRH), luteinizing hormone-releasing hormone (LHRH), and dopamine (DA). The use of c-Fos expression has permitted functional neuroanatomical mapping of these systems in response to specific stimuli such as cholecystokinin (CCK), hyperosmolality, and volume depletion, or during various physiological states such as the proestrous ovulatory luteinizing hormone (LH) surge and lactation. Although the use of c-Fos as a marker of neuronal activation will continue to be an extremely powerful technique, future studies will also be directed at relating immediate early gene expression to changes in neuroendocrine gene expression. To this end, we have shown that both c-Fos and c-Jun are expressed in neuroendocrine neurons in response to a number of stimuli, setting the stage for potential regulatory drive to genes containing AP-1 binding sites. In addition, by using double-label in situ hybridization techniques, it should be possible to compare gene expression in activated neurons (as determined by the presence of c-Fos mRNA) and unactivated neurons, thus permitting immediate early gene expression to move beyond its present use as a marker of neuronal activation to an assessment of its role in the promotion of specific neuropeptide gene expression.

AB - Expression of c-Fos, or other immediate early gene products, by individual neurons can be used as a marker of cell activation, making staining of these proteins an extremely useful technique for functional anatomical mapping of neuroendocrine systems. Because these proteins are located in the nucleus, identification of the phenotype of the activated neuron using substances located within the cytoplasm can be accomplished with standard double-labeling immunocytochemical techniques. Although it is clear that neurons have the capacity to express a number of immediate early gene products, what remains to be established is whether there is a different pattern of expression following various stimuli. In our studies, we focus primarily on expression of one immediate early gene product, the c-Fos protein. We also include some experiments using expression of other members of the Fos family and Jun proteins as markers for neuronal activation. Our studies describe uses of c-Fos expression in both parvocellular and magnocellular hypothalamic systems to address the following issues: (a) identification of neuroendocrine cells activated by specific treatments and conditions, (b) ascertainment of functional differences in subpopulations activated by specific stimuli, (c) evaluation of neuronal activity in complex areas containing multiple neuroendocrine systems, (d) identification of other brain areas activated in conjunction with neuroendocrine systems following specific stimuli, (e) analysis of connectivity of activated neuroendocrine systems with other parts of the brain, and (f) identification of stimuli that decrease neuronal activity. The neuroendocrine systems studied include those that secrete arginine vasopressin (AVP), oxytocin (OT), corticotropin-releasing hormone (CRH), luteinizing hormone-releasing hormone (LHRH), and dopamine (DA). The use of c-Fos expression has permitted functional neuroanatomical mapping of these systems in response to specific stimuli such as cholecystokinin (CCK), hyperosmolality, and volume depletion, or during various physiological states such as the proestrous ovulatory luteinizing hormone (LH) surge and lactation. Although the use of c-Fos as a marker of neuronal activation will continue to be an extremely powerful technique, future studies will also be directed at relating immediate early gene expression to changes in neuroendocrine gene expression. To this end, we have shown that both c-Fos and c-Jun are expressed in neuroendocrine neurons in response to a number of stimuli, setting the stage for potential regulatory drive to genes containing AP-1 binding sites. In addition, by using double-label in situ hybridization techniques, it should be possible to compare gene expression in activated neurons (as determined by the presence of c-Fos mRNA) and unactivated neurons, thus permitting immediate early gene expression to move beyond its present use as a marker of neuronal activation to an assessment of its role in the promotion of specific neuropeptide gene expression.

KW - Arginine vasopressin

KW - c-Fos

KW - Cholecystokinin

KW - Corticotropin releasing hormone

KW - Dopamine

KW - Fos-related antigens

KW - Immediate early gene expression

KW - Jun

KW - Luteinizing hormone releasing hormone

KW - Neuroanatomical mapping

KW - Oxytocin

KW - Protooncogenes

UR - http://www.scopus.com/inward/record.url?scp=0027309213&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027309213&partnerID=8YFLogxK

M3 - Article

C2 - 8349003

AN - SCOPUS:0027309213

VL - 14

SP - 173

EP - 213

JO - Frontiers in Neuroendocrinology

JF - Frontiers in Neuroendocrinology

SN - 0091-3022

IS - 3

ER -